Antimicrobial Proteins – Function & Importance

What are Antimicrobial Proteins?

Antimicrobial proteins (also called antimicrobial peptides, or AMPs) are a diverse group of molecules produced by the human body, as well as by animals, plants, and microorganisms. They serve as a first line of defense against pathogens such as bacteria, viruses, fungi, and parasites. In humans, they are a key component of the innate immune system, acting rapidly and without the need for prior sensitization.

Classification and Examples

Antimicrobial proteins are classified into several groups based on their structure, origin, and mechanism of action:

• Defensins: Small, cysteine-rich peptides found in neutrophils, epithelial cells, and other tissues. They are divided into alpha-, beta-, and theta-defensins.
• Cathelicidins: For example, LL-37 in humans. Produced in leukocytes and epithelial cells, they have a broad antimicrobial spectrum.
• Lysozyme: An enzyme present in saliva, tears, and breast milk that breaks down bacterial cell walls.
• Lactoferrin: An iron-binding protein found in body fluids that deprives bacteria of the iron they need for growth.
• Histatins: Proteins in saliva with antifungal properties.
• Psoriasin (S100A7): An antimicrobial protein found in the skin.

Mechanism of Action

Antimicrobial proteins act through several distinct mechanisms:

• Membrane disruption: Many AMPs insert themselves into the cell membrane of pathogens and create pores, leading to cell death.
• Inhibition of cell wall synthesis: Some proteins, such as lysozyme, degrade specific components of the bacterial cell wall.
• Iron sequestration: Lactoferrin binds iron that is essential for bacterial growth, thereby inhibiting pathogen proliferation.
• Immunomodulation: In addition to direct antimicrobial effects, many of these molecules can activate immune cells, regulate inflammatory responses, and support wound healing.
• Inhibition of nucleic acid synthesis: Some AMPs can penetrate pathogen cells and interfere with DNA or RNA synthesis.

Occurrence in the Human Body

Antimicrobial proteins are produced at numerous locations throughout the body, particularly at sites in contact with the external environment:

• Skin and mucous membranes (e.g., mouth, gut, airways, urogenital tract)
• Tear fluid, saliva, and breast milk
• Blood and bone marrow (in immune cells such as neutrophils)
• Lungs and airway secretions

Medical Significance

Understanding antimicrobial proteins has become increasingly important in modern medicine. A deficiency or reduced activity of these proteins can lead to increased susceptibility to infections, as seen in certain skin conditions such as Crohn's disease, psoriasis, and atopic dermatitis. Conversely, excessive activity may contribute to chronic inflammatory states.

Due to the growing problem of antibiotic resistance, antimicrobial peptides are considered promising candidates for new anti-infective therapeutic approaches. Numerous AMPs are currently being investigated in clinical trials as potential new antibiotics or antivirals.

Diagnostic and Therapeutic Relevance

In research, antimicrobial proteins are being studied as biomarkers for infections and inflammation. In dermatology, they help explain differences in infection susceptibility in skin diseases. Therapeutically, the first AMP-based preparations, such as daptomycin (a lipopeptide antibiotic) and various topical applications, are already in clinical use.

References

1. Zasloff, M. (2002). Antimicrobial peptides of multicellular organisms. Nature, 415(6870), 389–395. https://doi.org/10.1038/415389a
2. Hancock, R. E. W. & Sahl, H. G. (2006). Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nature Biotechnology, 24(12), 1551–1557. https://doi.org/10.1038/nbt1267
3. World Health Organization (WHO). (2021). Antimicrobial resistance. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance